Botensilimab/Balstilimab Clinical Responses in Refractory Sarcomas Presented at ESMO 2024

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/14/2026

1. CSCO
2. CBRS
3. COHR
4. SPY
5. BTGO
6. NVDA
7. WYFI
8. STUB
9. ARX
10. EAT

Go back to Botensilimab/Balstilimab Clinical Responses in Refractory Sarcomas Presented at ESMO 2024
AGENUS (NASDAQ: AGEN) Delayed: 7.00 +0.10 (1.45%)
Previous Close $6.90    52 Week High $7.49 
Open $6.85    52 Week Low $2.61 
Day High $7.03    P/E N/A 
Day Low $6.71    EPS $-1.10 
Volume 624,934